Glycolic Acid for Acne: What the Evidence Shows

Quick Summary

The 2024 AAD guideline found the available evidence insufficient to make any recommendation on glycolic acid for acne, twice over: once for topical glycolic acid, and again for glycolic acid chemical peels, which appear in the guideline’s separate physical-modalities statement. The acne trials that do exist are almost all in-clinic chemical peels at 35 to 40 percent, not the low-strength…

Serum dropper held above an amber glass bottle
Where the guideline standsInsufficient evidence to recommend either way
AvailabilityOver the counter
How long before you judge itUnclear
PregnancyDiscuss with your clinician.
Sources behind this page6, every one linked at the bottom
Glycolic Acid for Acne at a glance. Recommendation strength and evidence certainty are separate axes under GRADE.

What it is

Glycolic acid is the smallest of the alpha hydroxy acids, originally isolated from sugar cane. Because the molecule is small and water-soluble it moves readily into the outer layer of skin, where it weakens the bonds holding dead cells together. The result is faster shedding of the surface layer, which is the basis for the claim that it clears the plugged follicles acne starts from. How strongly it acts depends on concentration and on pH, not concentration alone. It turns up in two quite different forms: leave-on lotions and toners, which the US Cosmetic Ingredient Review panel considers safe at 10 percent or less with a pH of 3.5 or above, and in-clinic peels at much higher strengths. Unlike salicylic acid, it is not oil-soluble, so it does not concentrate inside the sebaceous follicle.

What the evidence actually shows

The guideline’s topical-agent statement reads: “Available evidence is insufficient to develop a recommendation on the use of topical glycolic acid, sulfur, sodium sulfacetamide, and resorcinol for acne treatment or to make recommendations that compare topical BP, retinoids, antibiotics, and their combinations directly against each other.” That is a separate sentence from the one covering complementary and alternative therapies. Glycolic acid is in fact named twice in the guideline: once as a topical agent in the sentence above, and again in the physical-modalities statement, which finds the evidence insufficient to develop a recommendation on “chemical peels (including glycolic acid, trichloroacetic acid, salicylic acid, Jessner’s solution, or mandelic acid)”. The peel trials described below fall under that second statement.

Replace ‘screened 49 randomised trials in 3,880 participants’ with ‘included 49 randomised trials in 3,880 participants’. Its entire alpha hydroxy acid result was a single comparison: glycolic acid peel versus salicylic-mandelic acid peel, with no difference in physician global assessment (RR 1.06, 95% CI 0.88 to 1.26; 1 study, 40 participants, low-quality evidence). No glycolic acid comparison against a vehicle or against a standard acne drug appeared at all.

A 2018 BMJ Open systematic review of chemical peels pooled 12 randomised trials in 387 participants and rated their methodological quality very low to moderate. Glycolic acid beat placebo for excellent or good improvement (RR 2.30, 95% CI 1.40 to 3.77), showed no significant difference against amino fruit acid or against Jessner’s solution, and was outperformed by a salicylic-mandelic peel (85.3 versus 68.5 percent improvement). The placebo comparison rests largely on a 2014 randomised, double-blind, split-face trial in which 26 patients with moderate acne received five sessions of 40 percent glycolic acid at two-week intervals against placebo on the other half of the face; it worked better on non-inflammatory lesions than on inflamed ones. A 2009 trial in 44 patients found a salicylic-mandelic peel better than 35 percent glycolic acid for both active acne and post-acne pigmentation.

So the guideline was looking at a few dozen patients per question, all studied as a clinic procedure, over a handful of weeks. That is why it stopped short of a recommendation either way.

How it is actually used

This is not something to seek out on the strength of its acne evidence. Benzoyl peroxide and topical retinoids carry strong recommendations in the same guideline; salicylic acid carries a conditional one. If you already use a glycolic acid product for texture or marks, the cosmetic safe-use range is 10 percent or less at a pH of 3.5 or above, applied at night, starting two or three times a week. Nothing in the trial literature tells you what that does for acne, because the trials tested clinic peels. A peel course in those studies ran to five or six sessions at fortnightly intervals. Daily sunscreen is not optional alongside it. Introduce it separately from a retinoid or benzoyl peroxide rather than starting everything at once.

Safety and who should avoid it

The FDA states that applying alpha hydroxy acids increases UV sensitivity: after four weeks of use, volunteers’ sensitivity to UV-induced skin reddening rose by 18 percent and their sensitivity to UV-induced cellular damage doubled on average, with considerable variation between individuals. The effect was gone a week after treatment stopped. The FDA recommends a sunburn alert on the label advising sunscreen during use and for a week afterwards. Expect stinging, redness and dryness, more so at higher strengths. Higher-strength peels carry a risk of post-inflammatory pigmentation, which matters more in deeper skin tones. Safety in pregnancy has not been established for this use; discuss it with your clinician.

Commonly repeated: Glycolic acid is a proven acne treatment. What the evidence actually shows: almost all of the acne trial data come from in-clinic chemical peels at 35 to 40 percent given in a series of five or six sessions, not from the 5 to 10 percent leave-on products most people actually buy, and DELETE the clause; the preceding sentence about the trial base consisting of peels already carries the point and is the narrower, verified claim.. Where glycolic acid has been compared head-to-head with a salicylic-mandelic peel, it did worse for both active acne and post-acne pigmentation. The 2024 AAD guideline names topical glycolic acid in its insufficient-evidence statement for topical agents, and names glycolic acid chemical peels again in its separate insufficient-evidence statement for physical modalities.

Sources

Keep reading

See where this sits against every other acne treatment on the acne treatment evidence map, or check how it combines with another ingredient in the ingredient combination checker. For the guideline’s own wording on this, see the 2024 AAD guideline, recommendation by recommendation.

Not medical advice

This page reports what the published evidence says about a treatment. It is not a treatment plan and it cannot account for your skin, your other medications or your medical history. Nothing here has been reviewed by a clinician; see our editorial policy for what that means. Talk to a clinician before starting or stopping any prescription treatment.

Written by

Research, not medical advice. Every clinical claim above links to the guideline, systematic review, trial or drug label it came from, so you can check it yourself rather than take my word for it. It was researched and drafted with AI assistance by a non-clinician, and no dermatologist has reviewed it: this site does the reading, it doesn’t practise medicine. It can’t account for your circumstances either, so talk to a dermatologist or doctor about your own skin, especially before starting or stopping a prescription treatment.